amobarbital has been researched along with Day Blindness in 2 studies
Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Significant visual impairment in the eye ipsilateral to injection (EII) occurred in 7 of 16 patients ranging from blurring to complete, transient loss of vision." | 1.29 | Ocular dysfunction during the amytal suppression test. ( DeToledo, J; Smith, DB; Stanulis, R, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DeToledo, J | 1 |
| Smith, DB | 1 |
| Stanulis, R | 1 |
| Lefkowitz, M | 1 |
| Giannotta, SL | 1 |
| Hieshima, G | 1 |
| Higashida, R | 1 |
| Halbach, V | 1 |
| Dowd, C | 1 |
| Teitelbaum, GP | 1 |
2 other studies available for amobarbital and Day Blindness
| Article | Year |
|---|---|
Ocular dysfunction during the amytal suppression test.
Topics: Amobarbital; Eye; Female; Functional Laterality; Humans; Male; Pupil; Reflex, Pupillary; Task Perfor | 1993 |
Embolization of neurosurgical lesions involving the ophthalmic artery.
Topics: Adolescent; Adult; Aged; Amobarbital; Angiofibroma; Arteriovenous Fistula; Arteriovenous Malformatio | 1998 |